Name: Vivos Therapeutics, Inc. (VVOS) Financial Statements
Creator: FinSpry

Vivos Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scale:

Scroll to see more

Vivos Therapeutics, Inc. income statement - Annual data in billions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.02	0.01	0.02	0.02	0.01
Cost of Revenue	0.01	0.01	0.01	0.00	0.00
Gross Profit	0.01	0.01	0.01	0.01	0.01
Operating Expenses
Research & Development	0.00	0.00	0.00	0.00	0.00
Selling, General & Administrative	0.02	0.02	0.03	0.03	0.02
Operating Expenses	0.02	0.03	0.04	0.03	0.02
Operating Income	-0.01	-0.02	-0.03	-0.02	-0.01
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00	0.00
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	0.00	0.00	0.00	0.00	0.00
Income
Income Before Tax	-0.01	-0.01	-0.02	-0.02	-0.01
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-0.01	-0.01	-0.02	-0.02	-0.01
Net Income - Continuous Operations	-0.01	-0.01	-0.02	-0.02	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-0.01	-0.02	-0.02	-0.02	-0.01
EBIT	-0.01	-0.02	-0.02	-0.02	-0.01
Depreciation & Amortization	0.00	0.00	0.00	0.00	0.00
Earnings Per Share
Basic EPS	-2.00	-11.00	-1.00	-24.00	-35.00
Diluted EPS	-2.00	-11.00	-1.00	-24.00	-35.00
Basic Shares Outstanding	0.01	0.00	23.01	0.00	0.00
Diluted Shares Outstanding	0.01	0.00	23.01	0.00	0.00